{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:58:37Z","timestamp":1793663917698,"version":"4.5.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2019-12369247"],"award-info":[{"award-number":["RF-2019-12369247"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RRC 2018-2023"],"award-info":[{"award-number":["RRC 2018-2023"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RCR-2021-23671214"],"award-info":[{"award-number":["RCR-2021-23671214"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR-MR1-2022-12376618"],"award-info":[{"award-number":["PNRR-MR1-2022-12376618"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Moyamoya angiopathy (MA) is a rare cerebrovascular disorder which can occur in both children and young adults, characterized by progressive occlusion of the intracranial carotid arteries, leading patients to ischemic and haemorrhagic strokes. Despite decades of research, the mechanisms underlying MA remain poorly clarified and current gaps in the understanding of pathogenesis have hampered the development of suitable preventive strategies and therapeutic options. Moreover, clinically approved biomarkers for MA patients\u2019 stratification are missing. The unknown pathophysiology and the lack of reliable biomarkers prompted us to investigate cerebrospinal fluid (CSF) lipidome through state-of-the-art lipidomics. <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Intraoperative CSF from a subgroup of MA patients in comparison to age\/sex matched controls (CTRL) was analysed through LC\u2013MS\/MS, by an untargeted lipidomic approach. Receiver operating characteristic (ROC) curve and simple linear regression analyses were performed for diagnostic use. We searched for simultaneously altered lipids in plasma and CSF of MA patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Overall, we observed a significant increase of sphingolipids (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and phospholipids (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) in MA CSF. A partial least squares discriminant analysis clearly separated MA and CTRL by 64% on Principal Component 1. We identified lipid classes (n\u2009=\u200912) with a Variance Importance in Projection score\u2009\u2265\u20091.5, within those lipids highly correlated with MA (n\u2009=\u200970). A significant increase in acylcarnitines, sphingolipids (sphingomyelins and ceramides), phospholipids (lysophosphatidylcholines; phosphatidylcholines; phosphatidylethanolamines; ether-phosphatidylethanolamines; ether-phosphatidylcholines) and cholesterol esters was found by multivariate and univariate analyses. Monoacylglycerols were the only lipid class displaying a markedly significant (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) decrease in CSF of MA patients as compared to CTRL subjects. The ROC curve and simple linear regression analysis identified 10 out of 12 lipid classes as reliable MA biomarkers, mainly dealing with phospholipids. We then compared current and previous data on plasma lipidomic profile. The discriminant analysis returned n\u2009=\u2009175 (in plasma) and n\u2009=\u200970 (in CSF) simultaneously altered lipids respectively, and phosphatidylcholines (n\u2009=\u200910) resulted as commonly decreased in plasma and increased in CSF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings highlighted a strong pro-inflammatory environment in MA CSF. These preliminary hallmarks could be helpful to decipher the complex MA pathogenesis, by supplying candidate biomarkers for patient stratification.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03782-5","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:03:01Z","timestamp":1747994581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipidomic profiling of the cerebrospinal fluid in moyamoya angiopathy patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Antonella","family":"Potenza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gorla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Carrozzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Pollaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Dei Cas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Acerbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio G.","family":"Vetrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ferroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Canavero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Paroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Rifino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bersano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-5031","authenticated-orcid":false,"given":"Laura","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"2","key":"3782_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10143-018-0994-5","volume":"43","author":"S Shang","year":"2020","unstructured":"Shang S, Zhou D, Ya J, Li S, Yang Q, Ding Y, et al. Progress in moyamoya disease. Neurosurg Rev. 2020;43(2):371\u201382. https:\/\/doi.org\/10.1007\/s10143-018-0994-5.","journal-title":"Neurosurg Rev"},{"issue":"8","key":"3782_CR2","first-page":"49","volume":"16","author":"S Guey","year":"2015","unstructured":"Guey S, Tournier-Lasserve E, Herv\u00e9 D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;16(8):49\u201368.","journal-title":"Appl Clin Genet"},{"issue":"6","key":"3782_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3171\/jns.2000.93.6.0976","volume":"93","author":"E Kobayashi","year":"2000","unstructured":"Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A. Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg. 2000;93(6):976\u201380. https:\/\/doi.org\/10.3171\/jns.2000.93.6.0976.","journal-title":"J Neurosurg"},{"key":"3782_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.wneu.2017.01.012","volume":"100","author":"JC Mejia-Munne","year":"2017","unstructured":"Mejia-Munne JC, Ellis JA, Feldstein NA, Meyers PM, Connolly ES. Moyamoya and inflammation. World Neurosurg. 2017;100:575\u20138. https:\/\/doi.org\/10.1016\/j.wneu.2017.01.012.","journal-title":"World Neurosurg."},{"issue":"10","key":"3782_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2176\/nmc.ra.2019-0059","volume":"59","author":"T Mikami","year":"2019","unstructured":"Mikami T, Suzuki H, Komatsu K, Mikuni N. Influence of inflammatory disease on the pathophysiology of moyamoya disease and quasi-moyamoya disease. Neurol Med Chir (Tokyo). 2019;59(10):361\u201370. https:\/\/doi.org\/10.2176\/nmc.ra.2019-0059.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"14","key":"3782_CR6","doi-asserted-by":"publisher","first-page":"661611","DOI":"10.3389\/fneur.2023.661611","volume":"16","author":"KB Dorschel","year":"2023","unstructured":"Dorschel KB, Wanebo JE. Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. Front Neurol. 2023;16(14):661611. https:\/\/doi.org\/10.3389\/fneur.2023.661611.","journal-title":"Front Neurol"},{"issue":"1","key":"3782_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10143-023-02123-z","volume":"46","author":"R Singh","year":"2023","unstructured":"Singh R, Bauman MMJ, Seas A, Harrison DJ, Pennington Z, Brown NJ, et al. Association of moyamoya vasculopathy with autoimmune disease: a systematic review and pooled analysis. Neurosurg Rev. 2023;46(1):220. https:\/\/doi.org\/10.1007\/s10143-023-02123-z.","journal-title":"Neurosurg Rev"},{"issue":"11","key":"3782_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","volume":"28","author":"C Asselman","year":"2022","unstructured":"Asselman C, Hemelsoet D, Eggermont D, Dermaut B, Impens F. Moyamoya disease emerging as an immune-related angiopathy. Trends Mol Med. 2022;28(11):939\u201350. https:\/\/doi.org\/10.1016\/j.molmed.2022.08.009.","journal-title":"Trends Mol Med"},{"key":"3782_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1172-8-45","volume":"8","author":"TK Sigdel","year":"2013","unstructured":"Sigdel TK, Shoemaker LD, Chen R, Li L, Butte AJ, Sarwal MM, et al. Immune response profiling identifies autoantibodies specific to moyamoya patients. Orphanet J Rare Dis. 2013;8:45. https:\/\/doi.org\/10.1186\/1750-1172-8-45.","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"3782_CR10","doi-asserted-by":"publisher","first-page":"724969","DOI":"10.3389\/fneur.2021.724969","volume":"8","author":"JD Santoro","year":"2021","unstructured":"Santoro JD, Lee S, Wang AC, Ho E, Nagesh D, Khoshnood M, et al. Increased autoimmunity in individuals with down syndrome and moyamoya disease. Front Neurol. 2021;8(12):724969. https:\/\/doi.org\/10.3389\/fneur.2021.724969.","journal-title":"Front Neurol"},{"key":"3782_CR11","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.11.037","volume":"27","author":"LA Lanterna","year":"2018","unstructured":"Lanterna LA, Galliani S, Zangari R, Conti L, Brembilla C, Gritti P, et al. Thyroid autoantibodies and the clinical presentation of moyamoya disease: a prospective study. J Stroke Cerebrovasc Dis. 2018;27:1194\u20139. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.11.037.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3782_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jocn.2022.02.036","volume":"99","author":"CH Sum","year":"2022","unstructured":"Sum CH, Tsang ACO, Cheng KK, Ho WW, Leung GKK, Lui WM. Surgical revascularization for moyamoya angiopathy: clinical and radiological outcomes of direct and indirect bypasses in 86 affected hemispheres. J Clin Neurosci. 2022;99:66\u201372. https:\/\/doi.org\/10.1016\/j.jocn.2022.02.036.","journal-title":"J Clin Neurosci"},{"issue":"4","key":"3782_CR13","first-page":"105","volume":"14","author":"AM Young","year":"2013","unstructured":"Young AM, Karri SK, Ogilvy CS, Zhao N. Is there a role for treating inflammation in moyamoya disease? A review of histopathology, genetics, and signaling cascades. Front Neurol. 2013;14(4):105.","journal-title":"Front Neurol"},{"issue":"8","key":"3782_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/ejhg.2017.92","volume":"25","author":"S Guey","year":"2017","unstructured":"Guey S, Kraemer M, Herv\u00e9 D, Ludwig T, Kossorotoff M, Bergametti F, et al. FREX consortium. Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians. Eur J Hum Genet. 2017;25(8):995\u20131003. https:\/\/doi.org\/10.1038\/ejhg.2017.92.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"3782_CR15","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3892\/etm.2019.7198","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med. 2019;17(3):1977\u201384. https:\/\/doi.org\/10.3892\/etm.2019.7198.","journal-title":"Exp Ther Med"},{"issue":"8","key":"3782_CR16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","volume":"79","author":"T Baba","year":"2008","unstructured":"Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79(8):900\u20134. https:\/\/doi.org\/10.1136\/jnnp.2007.130666.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"3782_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56(1):34\u201340. https:\/\/doi.org\/10.1038\/jhg.2010.132.","journal-title":"J Hum Genet"},{"issue":"9","key":"3782_CR18","doi-asserted-by":"publisher","first-page":"929871","DOI":"10.3389\/fsurg.2022.929871","volume":"1","author":"L Cao","year":"2022","unstructured":"Cao L, Dong Y, Sun K, Li D, Wang H, Li H, et al. Experimental animal models for moyamoya disease: a species-oriented scoping review. Front Surg. 2022;1(9):929871. https:\/\/doi.org\/10.3389\/fsurg.2022.929871.","journal-title":"Front Surg"},{"issue":"6","key":"3782_CR19","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/ene.15273","volume":"29","author":"M Correia","year":"2022","unstructured":"Correia M, Silva I, Gabriel D, Simr\u00e9n J, Carneiro A, Ribeiro S, et al. Early plasma biomarker dynamic profiles are associated with acute ischemic stroke outcomes. Eur J Neurol. 2022;29(6):1630\u201342. https:\/\/doi.org\/10.1111\/ene.15273.","journal-title":"Eur J Neurol"},{"issue":"4","key":"3782_CR20","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1227\/neu.0000000000002510","volume":"93","author":"I Micha\u00eblsson","year":"2023","unstructured":"Micha\u00eblsson I, Hall\u00e9n T, Carstam L, Laesser M, Bj\u00f6rkman-Burtscher IM, S\u00f6rbo A, et al. Circulating brain injury biomarkers: a novel method for quantification of the impact on the brain after tumor surgery. Neurosurgery. 2023;93(4):847\u201356. https:\/\/doi.org\/10.1227\/neu.0000000000002510.","journal-title":"Neurosurgery"},{"issue":"45","key":"3782_CR21","doi-asserted-by":"publisher","first-page":"e202210121","DOI":"10.1002\/anie.202210121","volume":"61","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Yue H, Cao B, Li Y, Yang M, Mao C. Target-triggered formation of artificial enzymes on filamentous phage for ultrasensitive direct detection of circulating mirna biomarkers in clinical samples. Angew Chem Int Ed Engl. 2022;61(45):e202210121. https:\/\/doi.org\/10.1002\/anie.202210121.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"2","key":"3782_CR22","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1002\/ctd2.270","volume":"4","author":"L Gatti","year":"2024","unstructured":"Gatti L, Bersano A, Gorla G, Pollaci G, Carrozzini T, Potenza A. Multi-omic approaches for biomarker discovery in moyamoya disease. Ann Clin Transl Neurol. 2024;4(2):e270. https:\/\/doi.org\/10.1002\/ctd2.270.","journal-title":"Ann Clin Transl Neurol"},{"issue":"13","key":"3782_CR23","doi-asserted-by":"publisher","first-page":"11194","DOI":"10.3390\/ijms241311194","volume":"24","author":"T Carrozzini","year":"2023","unstructured":"Carrozzini T, Pollaci G, Gorla G, Potenza A, Rifino N, Acerbi F, et al. Proteome profiling of the dura mater in patients with moyamoya angiopathy. Int J Mol Sci. 2023;24(13):11194. https:\/\/doi.org\/10.3390\/ijms241311194.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3782_CR24","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s12031-022-02092-w","volume":"72","author":"Z Wang","year":"2022","unstructured":"Wang Z, Ji C, Han Q, Wang Z, Huang Y. Data-independent acquisition-based serum proteomic profiling of adult moyamoya disease patients reveals the potential pathogenesis of vascular changes. J Mol Neurosci. 2022;72(12):2473\u201385. https:\/\/doi.org\/10.1007\/s12031-022-02092-w.","journal-title":"J Mol Neurosci"},{"issue":"10","key":"3782_CR25","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1161\/STROKEAHA.120.032297","volume":"52","author":"X Wang","year":"2021","unstructured":"Wang X, Han C, Jia Y, Wang J, Ge W, Duan L. Proteomic profiling of exosomes from hemorrhagic moyamoya disease and dysfunction of mitochondria in endothelial cells. Stroke. 2021;52(10):3351\u201361. https:\/\/doi.org\/10.1161\/STROKEAHA.120.032297.","journal-title":"Stroke"},{"issue":"15","key":"3782_CR26","doi-asserted-by":"publisher","first-page":"1298385","DOI":"10.3389\/fneur.2024.1298385","volume":"15","author":"J Yu","year":"2024","unstructured":"Yu J, Chen T, Li X, Chen J, Wei W, Zhang J. Liquid chromatography coupled to mass spectrometry metabolomic analysis of cerebrospinal fluid revealed the metabolic characteristics of moyamoya disease. Front Neurol. 2024;15(15):1298385. https:\/\/doi.org\/10.3389\/fneur.2024.1298385.","journal-title":"Front Neurol"},{"issue":"12","key":"3782_CR27","doi-asserted-by":"publisher","first-page":"e1492","DOI":"10.1002\/ctm2.1492","volume":"13","author":"S He","year":"2023","unstructured":"He S, Wang Y, Liu Z, Zhang J, Hao X, Wang X, et al. Metabolomic signatures associated with pathological angiogenesis in moyamoya disease. Clin Transl Med. 2023;13(12):e1492. https:\/\/doi.org\/10.1002\/ctm2.1492.","journal-title":"Clin Transl Med"},{"issue":"9","key":"3782_CR28","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.3390\/ijms23094492","volume":"23","author":"G Pollaci","year":"2022","unstructured":"Pollaci G, Gorla G, Potenza A, Carrozzini T, Canavero I, Bersano A, et al. Novel multifaceted roles for RNF213 protein. Int J Mol Sci. 2022;23(9):4492. https:\/\/doi.org\/10.3390\/ijms23094492.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3782_CR29","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.bbamem.2009.08.016","volume":"1788","author":"J Fantini","year":"2009","unstructured":"Fantini J, Barrantes FJ. Sphingolipid\/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta. 2009;1788(11):2345\u201361. https:\/\/doi.org\/10.1016\/j.bbamem.2009.08.016.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"3782_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell. 2015;6(4):254\u201364. https:\/\/doi.org\/10.1007\/s13238-014-0131-3.","journal-title":"Protein Cell"},{"issue":"1","key":"3782_CR31","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1097\/JS9.0000000000002092","volume":"111","author":"K He","year":"2024","unstructured":"He K, Wang X, Gu Y, Tong X, Qin X, Liao Y, et al. In-depth cerebrovascular lipidomics profiling for discovering novel biomarkers and mechanisms in moyamoya and intracranial atherosclerotic disease. Int J Surg. 2024;111(1):1607\u201313. https:\/\/doi.org\/10.1097\/JS9.0000000000002092.","journal-title":"Int J Surg"},{"issue":"6","key":"3782_CR32","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/acn3.52076","volume":"11","author":"G Gorla","year":"2024","unstructured":"Gorla G, Potenza A, Carrozzini T, Pollaci G, Acerbi F, Vetrano IG, et al. Angiopoietin-2 associates with poor prognosis in moyamoya angiopathy. Ann Clin Transl Neurol. 2024;11(6):1590\u2013603. https:\/\/doi.org\/10.1002\/acn3.52076.","journal-title":"Ann Clin Transl Neurol"},{"issue":"24","key":"3782_CR33","doi-asserted-by":"publisher","first-page":"13410","DOI":"10.3390\/ijms222413410","volume":"22","author":"M Dei Cas","year":"2021","unstructured":"Dei Cas M, Carrozzini T, Pollaci G, Potenza A, Nava S, Canavero I, et al. Plasma lipid profiling contributes to untangle the complexity of moyamoya arteriopathy. Int J Mol Sci. 2021;22(24):13410. https:\/\/doi.org\/10.3390\/ijms222413410.","journal-title":"Int J Mol Sci"},{"key":"3782_CR34","doi-asserted-by":"publisher","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52(5):245\u201366. https:\/\/doi.org\/10.2176\/nmc.52.245","DOI":"10.2176\/nmc.52.245"},{"key":"3782_CR35","doi-asserted-by":"publisher","unstructured":"Bersano A, Bedini G, Nava S, Acerbi F, Sebastiano DR, Binelli S, et al.; GEN-O-MA study group. GEN-O-MA project: an Italian network studying clinical course and pathogenic pathways of moyamoya disease-study protocol and preliminary results. Neurol Sci. 2019;40(3):561\u2013570. https:\/\/doi.org\/10.1007\/s10072-018-3664-z.","DOI":"10.1007\/s10072-018-3664-z"},{"issue":"1","key":"3782_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/23969873221144089","volume":"8","author":"A Bersano","year":"2023","unstructured":"Bersano A, Khan N, Fuentes B, Acerbi F, Canavero I, Tournier-Lasserve E, et al. European stroke organisation (ESO) guidelines on moyamoya angiopathy endorsed by vascular European reference network (VASCERN). Eur Stroke J. 2023;8(1):55\u201384. https:\/\/doi.org\/10.1177\/23969873221144089.","journal-title":"Eur Stroke J"},{"issue":"3","key":"3782_CR37","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular, \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288\u201399. https:\/\/doi.org\/10.1001\/archneur.1969.00480090076012.","journal-title":"Arch Neurol"},{"key":"3782_CR38","unstructured":"MS-DIAL ver. 4.0. RIKEN Center for Sustainable Resource Science, Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, Japan. http:\/\/prime.psc.riken.jp\/compms \/msdial\/main.html. Accessed 29 Dec 2023."},{"key":"3782_CR39","unstructured":"MetaboLights Database. EMBL-EBI, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK. https:\/\/www.ebi.ac.uk\/metabolights\/editor\/study\/MTBLS9744\/descriptors. Accessed 15 May 2024"},{"key":"3782_CR40","unstructured":"MetaboAnalyst ver. 5.0. McGill Data Center and Compute Canada, Montr\u00e9al, Canada. https:\/\/www.metaboanalyst.ca. Accessed 17 Dec 2023"},{"issue":"16","key":"3782_CR41","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.3390\/ijms21165763","volume":"21","author":"F Tinelli","year":"2020","unstructured":"Tinelli F, Nava S, Arioli F, Bedini G, Scelzo E, Lisini D, et al. Vascular remodeling in moyamoya angiopathy: from peripheral blood mononuclear cells to endothelial cells. Int J Mol Sci. 2020;21(16):5763. https:\/\/doi.org\/10.3390\/ijms21165763.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"3782_CR42","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.3390\/jcm10163628","volume":"10","author":"I Canavero","year":"2021","unstructured":"Canavero I, Vetrano IG, Zedde M, Pascarella R, Acerbi F, et al. Clinical management of moyamoya patients. J Clin Med. 2021;10(16):3628. https:\/\/doi.org\/10.3390\/jcm10163628.","journal-title":"J Clin Med"},{"issue":"17","key":"3782_CR43","doi-asserted-by":"publisher","first-page":"1191609","DOI":"10.3389\/fncel.2023.1191609","volume":"2","author":"H Yuan","year":"2023","unstructured":"Yuan H, Zhu B, Li C, Zhao Z. Ceramide in cerebrovascular diseases. Front Cell Neurosci. 2023;2(17):1191609. https:\/\/doi.org\/10.3389\/fncel.2023.1191609.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"3782_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11064-004-9681-8","volume":"30","author":"RM Adibhatla","year":"2005","unstructured":"Adibhatla RM, Hatcher JF. Cytidine 5\u2019-diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem Res. 2005;30(1):15\u201323. https:\/\/doi.org\/10.1007\/s11064-004-9681-8.","journal-title":"Neurochem Res"},{"issue":"1","key":"3782_CR45","doi-asserted-by":"publisher","first-page":"22891","DOI":"10.1038\/s41598-021-02361-5","volume":"11","author":"D Magaquian","year":"2021","unstructured":"Magaquian D, Delgado Oca\u00f1a S, Perez C, Banchio C. Phosphatidylcholine restores neuronal plasticity of neural stem cells under inflammatory stress. Sci Rep. 2021;11(1):22891. https:\/\/doi.org\/10.1038\/s41598-021-02361-5.","journal-title":"Sci Rep"},{"issue":"7","key":"3782_CR46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/00004647-200207000-00007","volume":"22","author":"N Blondeau","year":"2002","unstructured":"Blondeau N, Lauritzen I, Widmann C, Lazdunski M, Heurteaux C. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J Cereb Blood Flow Metab. 2002;22(7):821\u201334. https:\/\/doi.org\/10.1097\/00004647-200207000-00007.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"13","key":"3782_CR47","doi-asserted-by":"publisher","first-page":"1047101","DOI":"10.3389\/fneur.2022.1047101","volume":"15","author":"M Huang","year":"2022","unstructured":"Huang M, Xu S, Zhou M, Luo J, Zha F, Shan L, et al. Lysophosphatidylcholines and phosphatidylcholines as biomarkers for stroke recovery. Front Neurol. 2022;15(13):1047101. https:\/\/doi.org\/10.3389\/fneur.2022.1047101.","journal-title":"Front Neurol"},{"issue":"13","key":"3782_CR48","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1212\/WNL.0000000000000264","volume":"82","author":"JY Choi","year":"2014","unstructured":"Choi JY, Kim JS, Kim JH, Oh K, Koh SB, Seo WK. High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients. Neurology. 2014;82(13):1142\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000000264.","journal-title":"Neurology"},{"issue":"9","key":"3782_CR49","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1161\/ATVBAHA.118.311373","volume":"38","author":"WK Seo","year":"2018","unstructured":"Seo WK, Jo G, Shin MJ, Oh K. Medium-chain acylcarnitines are associated with cardioembolic stroke and stroke recurrence. Arterioscler Thromb Vasc Biol. 2018;38(9):2245\u201353. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311373.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3782_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/bs.acc.2018.02.002","volume":"85","author":"A Au","year":"2018","unstructured":"Au A. Metabolomics and lipidomics of ischemic stroke. Adv Clin Chem. 2018;85:31\u201369. https:\/\/doi.org\/10.1016\/bs.acc.2018.02.002.","journal-title":"Adv Clin Chem"},{"issue":"10","key":"3782_CR51","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3389\/fneur.2019.01011","volume":"19","author":"R Sun","year":"2019","unstructured":"Sun R, Li Y, Cai M, Cao Y, Piao X. Discovery of a new biomarker pattern for differential diagnosis of acute ischemic stroke using targeted metabolomics. Front Neurol. 2019;19(10):1011. https:\/\/doi.org\/10.3389\/fneur.2019.01011.","journal-title":"Front Neurol"},{"issue":"6","key":"3782_CR52","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3945\/ajcn.116.130492","volume":"103","author":"M Guasch-Ferr\u00e9","year":"2016","unstructured":"Guasch-Ferr\u00e9 M, Zheng Y, Ruiz-Canela M, Hruby A, Mart\u00ednez-Gonz\u00e1lez MA, Clish CB, et al. Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions. Am J Clin Nutr. 2016;103(6):1408\u201316. https:\/\/doi.org\/10.3945\/ajcn.116.130492.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"3782_CR53","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1161\/ATVBAHA.111.234096","volume":"31","author":"PJ Meikle","year":"2011","unstructured":"Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, Christopher MJ, MacIntosh GL, Goudey B, Stern L, Kowalczyk A, Haviv I, White AJ, Dart AM, Duffy SJ, Jennings GL, Kingwell BA. Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol. 2011;31(11):2723\u201332. https:\/\/doi.org\/10.1161\/ATVBAHA.111.234096.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"3782_CR54","doi-asserted-by":"publisher","first-page":"e47990","DOI":"10.7554\/eLife.47990","volume":"16","author":"K Petkevicius","year":"2019","unstructured":"Petkevicius K, Virtue S, Bidault G, Jenkins B, \u00c7ubuk C, Morgantini C, et al. Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesity. Elife. 2019;16(8):e47990. https:\/\/doi.org\/10.7554\/eLife.47990.","journal-title":"Elife"},{"issue":"247","key":"3782_CR55","doi-asserted-by":"publisher","first-page":"117443","DOI":"10.1016\/j.lfs.2020.117443","volume":"15","author":"P Liu","year":"2020","unstructured":"Liu P, Zhu W, Chen C, Yan B, Zhu L, Chen X, Peng C. The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sci. 2020;15(247):117443. https:\/\/doi.org\/10.1016\/j.lfs.2020.117443.","journal-title":"Life Sci"},{"issue":"8","key":"3782_CR56","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1007\/s12035-018-1448-3","volume":"56","author":"K Czubowicz","year":"2019","unstructured":"Czubowicz K, J\u0119\u015bko H, Wencel P, Lukiw WJ, Strosznajder RP. The role of ceramide and sphingosine-1-phosphate in Alzheimer\u2019s disease and other neurodegenerative disorders. Mol Neurobiol. 2019;56(8):5455. https:\/\/doi.org\/10.1007\/s12035-018-1448-3.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"3782_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fendo.2013.00067","volume":"4","author":"SC Kang","year":"2013","unstructured":"Kang SC, Kim BR, Lee SY, Park TS. Sphingolipid metabolism and obesity-induced inflammation. Front Endocrinol (Lausanne). 2013;4(4):67. https:\/\/doi.org\/10.3389\/fendo.2013.00067.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"3782_CR58","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/jnnp-2020-324445","volume":"92","author":"G Capodivento","year":"2021","unstructured":"Capodivento G, De Michelis C, Carpo M, Fancellu R, Schirinzi E, Severi D, et al. CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS. J Neurol Neurosurg Psychiatry. 2021;92(3):303\u201310. https:\/\/doi.org\/10.1136\/jnnp-2020-324445.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"3782_CR59","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3174\/ajnr.A6708","volume":"41","author":"S Hara","year":"2020","unstructured":"Hara S, Hori M, Hagiwara A, Tsurushima Y, Tanaka Y, Maehara T, et al. Myelin and axonal damage in normal-appearing white matter in patients with moyamoya disease. AJNR Am J Neuroradiol. 2020;41(9):1618\u201324. https:\/\/doi.org\/10.3174\/ajnr.A6708.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3782_CR60","doi-asserted-by":"publisher","first-page":"487508","DOI":"10.1155\/2015\/487508","volume":"2015","author":"R Ghidoni","year":"2015","unstructured":"Ghidoni R, Caretti A, Signorelli P. Role of sphingolipids in the pathobiology of lung inflammation. Mediators Inflamm. 2015;2015:487508. https:\/\/doi.org\/10.1155\/2015\/487508.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"3782_CR61","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.plipres.2010.03.003","volume":"49","author":"S Gulati","year":"2010","unstructured":"Gulati S, Liu Y, Munkacsi AB, Wilcox L, Sturley SL. Sterols and sphingolipids: dynamic duo or partners in crime? Prog Lipid Res. 2010;49(4):353\u201365. https:\/\/doi.org\/10.1016\/j.plipres.2010.03.003.","journal-title":"Prog Lipid Res"},{"issue":"52","key":"3782_CR62","doi-asserted-by":"publisher","first-page":"35132","DOI":"10.1074\/jbc.273.52.35132","volume":"273","author":"CC Chang","year":"1998","unstructured":"Chang CC, Lee CY, Chang ET, Cruz JC, Levesque MC, Chang TY. Recombinant acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) purified to essential homogeneity utilizes cholesterol in mixed micelles or in vesicles in a highly cooperative manner. J Biol Chem. 1998;273(52):35132\u201341. https:\/\/doi.org\/10.1074\/jbc.273.52.35132.","journal-title":"J Biol Chem"},{"issue":"1","key":"3782_CR63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0022-510x(86)90190-5","volume":"74","author":"AS Pitk\u00e4nen","year":"1986","unstructured":"Pitk\u00e4nen AS, Halonen TO, Kilpel\u00e4inen HO, Riekkinen PJ. Cholesterol esterase activity in cerebrospinal fluid of multiple sclerosis patients. J Neurol Sci. 1986;74(1):45\u201353. https:\/\/doi.org\/10.1016\/0022-510x(86)90190-5.","journal-title":"J Neurol Sci"},{"issue":"4","key":"3782_CR64","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.10312","volume":"52","author":"RG Cutler","year":"2002","unstructured":"Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol. 2002;52(4):448\u201357. https:\/\/doi.org\/10.1002\/ana.10312.","journal-title":"Ann Neurol"},{"issue":"1","key":"3782_CR65","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1038\/s41598-018-33116-4","volume":"8","author":"MJ Gerl","year":"2018","unstructured":"Gerl MJ, Vaz WLC, Domingues N, Klose C, Surma MA, Sampaio JL, et al. Cholesterol is inefficiently converted to cholesteryl esters in the blood of cardiovascular disease patients. Sci Rep. 2018;8(1):14764. https:\/\/doi.org\/10.1038\/s41598-018-33116-4.","journal-title":"Sci Rep"},{"issue":"11","key":"3782_CR66","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","volume":"17","author":"E Brennan","year":"2021","unstructured":"Brennan E, Kantharidis P, Cooper ME, Godson C. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. Nat Rev Nephrol. 2021;17(11):725\u201339. https:\/\/doi.org\/10.1038\/s41581-021-00454-y.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"3782_CR67","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/gutjnl-2018-316137","volume":"68","author":"A Habib","year":"2019","unstructured":"Habib A, Chokr D, Wan J, Hegde P, Mabire M, Siebert M, et al. Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver. Gut. 2019;68(3):522\u201332. https:\/\/doi.org\/10.1136\/gutjnl-2018-316137.","journal-title":"Gut"},{"issue":"16","key":"3782_CR68","doi-asserted-by":"publisher","first-page":"10819","DOI":"10.1073\/pnas.152334899","volume":"99","author":"TP Dinh","year":"2002","unstructured":"Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A. 2002;99(16):10819\u201324. https:\/\/doi.org\/10.1073\/pnas.152334899.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6057","key":"3782_CR69","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1126\/science.1209200","volume":"334","author":"DK Nomura","year":"2011","unstructured":"Nomura DK, Morrison BE, Blankman JL, Long JZ, Kinsey SG, Marcondes MC, et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science. 2011;334(6057):809\u201313. https:\/\/doi.org\/10.1126\/science.1209200.","journal-title":"Science"},{"issue":"8","key":"3782_CR70","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.3390\/molecules18089704","volume":"18","author":"Y Cao","year":"2013","unstructured":"Cao Y, Wang W, Xu Y, Yang B, Wang Y. Enzymatic synthesis of extremely pure triacylglycerols enriched in conjugated linoleic acids. Molecules. 2013;18(8):9704\u201316. https:\/\/doi.org\/10.3390\/molecules18089704.","journal-title":"Molecules"},{"issue":"2","key":"3782_CR71","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jnc.14246","volume":"144","author":"E Camerer","year":"2018","unstructured":"Camerer E. Endotoxemia rocks sphingolipid metabolism at the blood-brain barrier: an Editorial Highlight for \u2018Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced BBB disruption\u2019 on page 172. J Neurochem. 2018;144(2):115\u20137. https:\/\/doi.org\/10.1111\/jnc.14246.","journal-title":"J Neurochem"},{"issue":"2","key":"3782_CR72","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00701-019-03811-w","volume":"161","author":"A Narducci","year":"2019","unstructured":"Narducci A, Yasuyuki K, Onken J, Blecharz K, Vajkoczy P. In vivo demonstration of blood-brain barrier impairment in moyamoya disease. Acta Neurochir (Wien). 2019;161(2):371\u20138. https:\/\/doi.org\/10.1007\/s00701-019-03811-w.","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"3782_CR73","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrm2330","volume":"9","author":"G van Meer","year":"2008","unstructured":"van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9(2):112\u201324. https:\/\/doi.org\/10.1038\/nrm2330.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"3782_CR74","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","volume":"29","author":"V Chiurchi\u00f9","year":"2018","unstructured":"Chiurchi\u00f9 V, Leuti A, Maccarrone M. Bioactive lipids and chronic inflammation: managing the fire within. Front Immunol. 2018;29(9):38. https:\/\/doi.org\/10.3389\/fimmu.2018.00038.","journal-title":"Front Immunol"},{"issue":"1","key":"3782_CR75","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12944-019-0965-z","volume":"18","author":"G Hussain","year":"2019","unstructured":"Hussain G, Wang J, Rasul A, Anwar H, Imran A, Qasim M, et al. Role of cholesterol and sphingolipids in brain development and neurological diseases. Lipids Health Dis. 2019;18(1):26. https:\/\/doi.org\/10.1186\/s12944-019-0965-z.","journal-title":"Lipids Health Dis"},{"key":"3782_CR76","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.addr.2020.04.009","volume":"159","author":"D van Kruining","year":"2020","unstructured":"van Kruining D, Luo Q, van Echten-Deckert G, Mielke MM, Bowman A, Ellis S, et al. Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods. Adv Drug Deliv Rev. 2020;159:232\u201344. https:\/\/doi.org\/10.1016\/j.addr.2020.04.009.","journal-title":"Adv Drug Deliv Rev"},{"issue":"17","key":"3782_CR77","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/1873-3468.14992","volume":"598","author":"M Santos","year":"2024","unstructured":"Santos M, Melo T, Maur\u00edcio T, Ferreira H, Domingues P, Domingues R. The non-enzymatic oxidation of phosphatidylethanolamine and phosphatidylserine and their intriguing roles in inflammation dynamics and diseases. FEBS Lett. 2024;598(17):2174\u201389. https:\/\/doi.org\/10.1002\/1873-3468.14992.","journal-title":"FEBS Lett"},{"issue":"9 Pt B","key":"3782_CR78","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","volume":"1859","author":"JN van der Veen","year":"2017","unstructured":"van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr. 2017;1859(9 Pt B):1558\u201372. https:\/\/doi.org\/10.1016\/j.bbamem.2017.04.006.","journal-title":"Biochim Biophys Acta Biomembr"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03782-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:03:07Z","timestamp":1747994587000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03782-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3782"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03782-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design was approved by the Ethics Committee of the Fondazione IRCCS Istituto Neurologico \u201cC. Besta\u201d of Milan (GEN-O-MA clinical study, report no. 12, 10\/01\/2014). Informed written consent for study participation and sample collection from all patients and controls were mandatory for study inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the individuals for the publication of any potentially identifiable images or data included in this article. Privacy procedures were applied to protect patients\u2019 and control subjects\u2019 personal identities.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"243"}}